Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study
Date
2021Author
Ozbalak, Murat
Akay, Olga Meltem
Pehlivan, Mustafa
Yildiz, Birol
Uzay, Ant
Yigenoglu, Tugce Nur
Elverdi, Tugrul
Kaynar, Leylagul
Ayyildiz, Orhan
Hindilerden, Ipek Yonal
Goksoy, Hasan Sami
Metadata
Show full item record
DSpace@İYYU by Istanbul Yeni Yüzyil University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..